| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 2.41e-04 | 16 | 29 | 2 | GO:0043138 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 2.79e-04 | 645 | 29 | 6 | GO:0140640 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 9.50e-04 | 134 | 29 | 3 | GO:0003697 | |
| Domain | VWA_2 | 2.32e-05 | 5 | 29 | 2 | PF13519 | |
| Domain | INT_SG_DDX_CT_C | 6.48e-05 | 8 | 29 | 2 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 6.48e-05 | 8 | 29 | 2 | IPR029307 | |
| Domain | USP_CS | 4.70e-03 | 66 | 29 | 2 | IPR018200 | |
| Domain | - | 4.82e-03 | 222 | 29 | 3 | 1.25.10.10 | |
| Domain | USP_1 | 5.27e-03 | 70 | 29 | 2 | PS00972 | |
| Domain | UCH | 5.41e-03 | 71 | 29 | 2 | PF00443 | |
| Domain | USP_2 | 5.41e-03 | 71 | 29 | 2 | PS00973 | |
| Domain | USP_3 | 5.56e-03 | 72 | 29 | 2 | PS50235 | |
| Domain | USP_dom | 5.56e-03 | 72 | 29 | 2 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 5.56e-03 | 72 | 29 | 2 | IPR001394 | |
| Domain | - | 5.87e-03 | 74 | 29 | 2 | 3.40.50.410 | |
| Domain | VWFA | 7.16e-03 | 82 | 29 | 2 | PS50234 | |
| Domain | VWA | 7.50e-03 | 84 | 29 | 2 | SM00327 | |
| Domain | EGF_CA | 7.85e-03 | 86 | 29 | 2 | PF07645 | |
| Domain | ARM-like | 8.27e-03 | 270 | 29 | 3 | IPR011989 | |
| Pubmed | USP2 promotes cell proliferation and metastasis in choroidal melanoma via stabilizing Snail. | 7.69e-07 | 2 | 31 | 2 | 37199836 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 3.38e-06 | 262 | 31 | 5 | 36880596 | |
| Pubmed | Characterization of two novel genes, WBSCR20 and WBSCR22, deleted in Williams-Beuren syndrome. | 4.61e-06 | 4 | 31 | 2 | 11978965 | |
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 35506169 | ||
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 1.29e-05 | 162 | 31 | 4 | 14743216 | |
| Pubmed | 3.22e-05 | 418 | 31 | 5 | 34709266 | ||
| Pubmed | Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma. | 3.44e-05 | 10 | 31 | 2 | 20601096 | |
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 26936881 | ||
| Pubmed | 3.99e-05 | 216 | 31 | 4 | 31519766 | ||
| Pubmed | Identification of additional transcripts in the Williams-Beuren syndrome critical region. | 4.21e-05 | 11 | 31 | 2 | 12073013 | |
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 8.02e-05 | 15 | 31 | 2 | 9827704 | |
| Pubmed | 1.02e-04 | 534 | 31 | 5 | 35032548 | ||
| Pubmed | A strategy for modulation of enzymes in the ubiquitin system. | 1.04e-04 | 17 | 31 | 2 | 23287719 | |
| Pubmed | 1.60e-04 | 21 | 31 | 2 | 27150455 | ||
| Pubmed | 1.93e-04 | 325 | 31 | 4 | 36168628 | ||
| Pubmed | 2.10e-04 | 24 | 31 | 2 | 31911859 | ||
| Pubmed | 2.47e-04 | 26 | 31 | 2 | 23435420 | ||
| Pubmed | 2.47e-04 | 26 | 31 | 2 | 28720576 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 2.77e-04 | 1489 | 31 | 7 | 28611215 | |
| Pubmed | 2.86e-04 | 28 | 31 | 2 | 29365100 | ||
| Pubmed | 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. | 3.29e-04 | 30 | 31 | 2 | 16306228 | |
| Pubmed | 3.52e-04 | 31 | 31 | 2 | 32546759 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 3.68e-04 | 704 | 31 | 5 | 29955894 | |
| Pubmed | 4.20e-04 | 399 | 31 | 4 | 37536630 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 4.65e-04 | 1149 | 31 | 6 | 35446349 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.07e-04 | 440 | 31 | 4 | 34244565 | |
| Pubmed | 7.16e-04 | 1247 | 31 | 6 | 27684187 | ||
| Pubmed | 8.46e-04 | 481 | 31 | 4 | 28190767 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 8.85e-04 | 212 | 31 | 3 | 33462405 | |
| Interaction | RTEL1 interactions | 3.34e-07 | 99 | 30 | 5 | int:RTEL1 | |
| Interaction | POLR2B interactions | 1.53e-05 | 371 | 30 | 6 | int:POLR2B | |
| Interaction | MCM7 interactions | 2.83e-05 | 414 | 30 | 6 | int:MCM7 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q12 | 5.35e-04 | 235 | 31 | 3 | chr22q12 | |
| Cytoband | 7q11.23 | 1.97e-03 | 97 | 31 | 2 | 7q11.23 | |
| GeneFamily | Integrator complex | 1.21e-04 | 15 | 20 | 2 | 1366 | |
| GeneFamily | Ubiquitin specific peptidases | 1.73e-03 | 56 | 20 | 2 | 366 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 6.21e-06 | 740 | 30 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 9.14e-06 | 357 | 30 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 1.13e-05 | 803 | 30 | 8 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | 2.36e-05 | 422 | 30 | 6 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_100 | 8.62e-05 | 10 | 30 | 2 | gudmap_developingGonad_e14.5_ epididymis_100_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 1.03e-04 | 804 | 30 | 7 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_top-relative-expression-ranked_100 | 1.20e-04 | 68 | 30 | 3 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.25e-04 | 184 | 30 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 1.42e-04 | 72 | 30 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.58e-04 | 371 | 30 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.74e-04 | 14 | 30 | 2 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 1.80e-04 | 78 | 30 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.85e-04 | 384 | 30 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 1.94e-04 | 388 | 30 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.24e-04 | 214 | 30 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | 2.62e-04 | 414 | 30 | 5 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.74e-04 | 418 | 30 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.94e-04 | 92 | 30 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 3.35e-04 | 973 | 30 | 7 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.69e-04 | 244 | 30 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 3.98e-04 | 249 | 30 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.03e-04 | 265 | 30 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 5.22e-04 | 24 | 30 | 2 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 5.24e-04 | 744 | 30 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.86e-04 | 276 | 30 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 6.63e-04 | 778 | 30 | 6 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 6.86e-04 | 783 | 30 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.06e-04 | 290 | 30 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_100 | 7.13e-04 | 28 | 30 | 2 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.37e-04 | 126 | 30 | 3 | gudmap_developingGonad_e14.5_ ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 7.43e-04 | 795 | 30 | 6 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 7.53e-04 | 797 | 30 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 7.73e-04 | 801 | 30 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.81e-04 | 298 | 30 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.19e-04 | 30 | 30 | 2 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 9.00e-04 | 135 | 30 | 3 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.19e-04 | 136 | 30 | 3 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 9.54e-04 | 834 | 30 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 9.66e-04 | 836 | 30 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_top-relative-expression-ranked_200 | 1.04e-03 | 142 | 30 | 3 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 1.06e-03 | 143 | 30 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.14e-03 | 330 | 30 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.15e-03 | 331 | 30 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 1.27e-03 | 152 | 30 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.29e-03 | 153 | 30 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.29e-03 | 589 | 30 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.36e-03 | 596 | 30 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 1.42e-03 | 158 | 30 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.47e-03 | 160 | 30 | 3 | gudmap_developingGonad_e18.5_ovary_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#3 | 1.47e-03 | 160 | 30 | 3 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.48e-03 | 607 | 30 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.51e-03 | 356 | 30 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 1.60e-03 | 165 | 30 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.64e-03 | 364 | 30 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 1.77e-03 | 372 | 30 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.84e-03 | 45 | 30 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.89e-03 | 642 | 30 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_200 | 1.92e-03 | 46 | 30 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.01e-03 | 385 | 30 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 2.01e-03 | 385 | 30 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.07e-03 | 655 | 30 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.09e-03 | 48 | 30 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 2.10e-03 | 973 | 30 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.12e-03 | 182 | 30 | 3 | gudmap_developingGonad_e16.5_ovary_1000_k1 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.46e-06 | 168 | 31 | 4 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.58e-06 | 169 | 31 | 4 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 154 | 31 | 3 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.68e-04 | 155 | 31 | 3 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-04 | 156 | 31 | 3 | b28bbdb515317368f1231b0b15d7442352f3b400 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-04 | 165 | 31 | 3 | b1bbf5acdfc52bd8c7c7eb356d73b812eb6b908c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-04 | 165 | 31 | 3 | 28f8297ec7b781149cc7ac2f5e441771083b8ee3 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 165 | 31 | 3 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 170 | 31 | 3 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-04 | 172 | 31 | 3 | 80b565f6e37f38629f4cf89d5b053b3b8517244e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 173 | 31 | 3 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 173 | 31 | 3 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-04 | 176 | 31 | 3 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 179 | 31 | 3 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-04 | 180 | 31 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-04 | 180 | 31 | 3 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-04 | 181 | 31 | 3 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.65e-04 | 181 | 31 | 3 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.69e-04 | 182 | 31 | 3 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 185 | 31 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-04 | 187 | 31 | 3 | 2c145e9d11424939dd99012a8cedf5d998b966e9 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 189 | 31 | 3 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-04 | 189 | 31 | 3 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-04 | 189 | 31 | 3 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-04 | 189 | 31 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.01e-04 | 189 | 31 | 3 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-04 | 191 | 31 | 3 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.10e-04 | 191 | 31 | 3 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.10e-04 | 191 | 31 | 3 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 192 | 31 | 3 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 192 | 31 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 192 | 31 | 3 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.15e-04 | 192 | 31 | 3 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 192 | 31 | 3 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 192 | 31 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-04 | 193 | 31 | 3 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.20e-04 | 193 | 31 | 3 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 193 | 31 | 3 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 193 | 31 | 3 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 193 | 31 | 3 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 3.20e-04 | 193 | 31 | 3 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 193 | 31 | 3 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.20e-04 | 193 | 31 | 3 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-04 | 194 | 31 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.25e-04 | 194 | 31 | 3 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-04 | 194 | 31 | 3 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 3.25e-04 | 194 | 31 | 3 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.30e-04 | 195 | 31 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-04 | 195 | 31 | 3 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.30e-04 | 195 | 31 | 3 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.30e-04 | 195 | 31 | 3 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.30e-04 | 195 | 31 | 3 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 195 | 31 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.30e-04 | 195 | 31 | 3 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-04 | 196 | 31 | 3 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-04 | 196 | 31 | 3 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-04 | 196 | 31 | 3 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-04 | 196 | 31 | 3 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-04 | 196 | 31 | 3 | 46d665de09f8164690b9a3e0acf0b0afa3f81b3d | |
| ToppCell | Healthy_donor-cDC|Healthy_donor / disease group, cell group and cell class (v2) | 3.40e-04 | 197 | 31 | 3 | b57a27e5b855bbdd1dfa352540599d260dc482aa | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-04 | 197 | 31 | 3 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | distal-mesenchymal-Lipofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.40e-04 | 197 | 31 | 3 | 865010edcd7e3f79f505fcef7b33882095994aa8 | |
| ToppCell | distal-mesenchymal-Lipofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.40e-04 | 197 | 31 | 3 | ceb83bdef16b58ee16193413bfb006f7715728b2 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.40e-04 | 197 | 31 | 3 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 197 | 31 | 3 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.45e-04 | 198 | 31 | 3 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.45e-04 | 198 | 31 | 3 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | COVID-19_Severe-cDC|World / disease group, cell group and cell class | 3.45e-04 | 198 | 31 | 3 | c452334249f047265ae89dcabe7de446d968cae6 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.50e-04 | 199 | 31 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.50e-04 | 199 | 31 | 3 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.50e-04 | 199 | 31 | 3 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-04 | 199 | 31 | 3 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 199 | 31 | 3 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.50e-04 | 199 | 31 | 3 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 199 | 31 | 3 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.50e-04 | 199 | 31 | 3 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | distal-1-mesenchymal-Lipofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.50e-04 | 199 | 31 | 3 | a8293db3c42a8d30897858b49aae7acfc18663ba | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-04 | 199 | 31 | 3 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 199 | 31 | 3 | 4217b9e66c5374461e84bdb893ab650f148286c8 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.55e-04 | 200 | 31 | 3 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 200 | 31 | 3 | 93c1db92e0e456101f7895867fc8a1fe45298347 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.55e-04 | 200 | 31 | 3 | 3be373e9a30e19334e4709e2819fb83cc777d104 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | 46d0ae385e67030bfaf7062bb6b43da5db05b33a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.55e-04 | 200 | 31 | 3 | c082bc21ec7c5323439d108ea8aea510e1113c3f | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.55e-04 | 200 | 31 | 3 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | 5'-GW_trimst-1|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.55e-04 | 200 | 31 | 3 | a4c6d0cccba7aee35eaedf29faff32b9494b6582 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-04 | 200 | 31 | 3 | d64895354218ebd0217011bae0967a6883bbd1cd | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.55e-04 | 200 | 31 | 3 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.55e-04 | 200 | 31 | 3 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.55e-04 | 200 | 31 | 3 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| Disease | triacylglycerol 56:2 measurement | 5.84e-05 | 11 | 31 | 2 | EFO_0010429 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 1.11e-04 | 15 | 31 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | breast cancer, ovarian carcinoma | 6.95e-04 | 37 | 31 | 2 | EFO_0001075, MONDO_0007254 | |
| Disease | Moyamoya disease | 8.13e-04 | 40 | 31 | 2 | MONDO_0016820 | |
| Disease | ovarian serous carcinoma | 1.07e-03 | 46 | 31 | 2 | EFO_1001516 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 1.17e-03 | 48 | 31 | 2 | C1862941 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 1.17e-03 | 48 | 31 | 2 | C4551993 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1.27e-03 | 50 | 31 | 2 | C1862939 | |
| Disease | Headache | 2.07e-03 | 64 | 31 | 2 | HP_0002315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRNSNMSIICCDSRI | 401 | Q7L0X2 | |
| TCVNSRTCAMINCQY | 131 | Q8IUX8 | |
| YECLRQSCNILISTM | 886 | Q14203 | |
| RMSQQAIRCTLVNCT | 106 | Q6ZN30 | |
| NYCSFKSQQCLMRNR | 486 | Q8NEB7 | |
| RSYCVRTQRMLNQCL | 206 | Q5JSJ4 | |
| RSYSVCSPRMLNQCL | 206 | Q9UL03 | |
| YSRCSINICQMTECI | 111 | Q9Y442 | |
| QCRSCRNTLTNIAMR | 171 | P33992 | |
| NQRCLSSSLRCNMFD | 3751 | Q07954 | |
| SLQRLVYSMCSLCQE | 166 | Q63ZY6 | |
| QRLVYSMCSLCQEEN | 86 | Q3KNT7 | |
| NCQSCCLQSYMRISI | 51 | Q8N690 | |
| RQCYRQMCNALCLFQ | 106 | P0C7M6 | |
| LLTRIQRYCNCNSSM | 606 | Q6VY07 | |
| LFQSNDQTLRRMCYL | 76 | Q9UBF2 | |
| LCYFCRISRQNQRSM | 2236 | P21817 | |
| RNGLLNCNDCYMRSR | 1061 | Q9UPQ0 | |
| QSVSCLQQLCMYLRN | 251 | Q86VV8 | |
| IRCCNVSSRMQSSIN | 2236 | Q93008 | |
| CRSCLENNCMRIYTT | 116 | Q15846 | |
| YCQNISKCRRVLMAQ | 446 | P46063 | |
| LVNLCQRCMDTRTYT | 676 | Q63HN8 | |
| CRPRTRMLCSQNTYT | 901 | Q9NRJ4 | |
| YQCQACARTFSRMSL | 236 | O95863 | |
| MCNLCQRSFRTFQAL | 1381 | Q86UP3 | |
| RRNNLFNRSCQSMTS | 1351 | Q96AY4 | |
| MTCRLSNNQRYLFLD | 136 | Q9BQ24 | |
| LNNGRLYSQCISMSR | 736 | Q92889 | |
| MRNRKYNCTLCSRSD | 1091 | Q9H9Y6 | |
| CFMNSILQCLSNTRE | 276 | O75604 |